Asaf Danziger Novo Cure LTD (NVCR) insider trading activity

Asaf Danziger is Chief Executive Officer of NovoCure Ltd. Currently has a direct ownership of 15,228 shares of NVCR, which is worth approximately $256,744. The most recent transaction as insider was on Jun 28, 2024, when has been sold 1,239 shares (Ordinary Shares) at a price of $12.24 per share, resulting in proceeds of $15,165. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.2K

0% 3M change

8.86% 12M change

Total Value Held $256,744

Asaf Danziger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 28 2024	BUY Grant, award, or other acquisition	$15,165 $12.24 p/Share	1,239 Added 7.52%	15,228 Ordinary Shares
Jun 30 2023	BUY Grant, award, or other acquisition	$12,947 $35.28 p/Share	367 Added 2.56%	13,989 Ordinary Shares
Jan 06 2023	BUY Grant, award, or other acquisition	$2,429 $62.3 p/Share	39 Added 0.29%	13,622 Ordinary Shares
Jan 05 2023	SELL Open market or private sale	$24,490,625 $115.25 p/Share	212,500 Reduced 93.99%	13,583 Ordinary Shares
Jan 05 2023	BUY Exercise of conversion of derivative security	$1,978,375 $9.31 p/Share	212,500 Added 51.38%	201,083 Ordinary Shares
Jul 05 2022	BUY Grant, award, or other acquisition	$16,306 $59.08 p/Share	276 Added 1.99%	13,583 Ordinary Shares
Jan 06 2022	BUY Grant, award, or other acquisition	$1,978 $63.82 p/Share	31 Added 0.23%	13,307 Ordinary Shares
Nov 26 2021	BUY Open market or private purchase	$501,081 $100.74 p/Share	4,974 Added 27.25%	13,276 Ordinary Shares
Jul 06 2021	BUY Grant, award, or other acquisition	$16,180 $137.12 p/Share	118 Added 1.4%	8,302 Ordinary Shares
Apr 13 2021	SELL Open market or private sale	$19,236,018 $196.34 p/Share	97,973 Reduced 92.29%	8,184 Ordinary Shares
Feb 27 2021	BUY Exercise of conversion of derivative security	$1,380,517 $149.1 p/Share	9,259 Added 4.28%	206,944 Ordinary Shares
Jan 06 2021	BUY Grant, award, or other acquisition	$2,686 $50.67 p/Share	53 Added 0.03%	197,685 Ordinary Shares
Dec 18 2020	SELL Open market or private sale	$33,369,555 $160.5 p/Share	207,910 Reduced 51.27%	197,632 Ordinary Shares
Dec 18 2020	BUY Exercise of conversion of derivative security	$4,574,020 $22.0 p/Share	207,910 Added 40.81%	301,587 Ordinary Shares

Asaf Danziger

Chief Executive Officer

Malvern, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVCR shares.

Notify only if

Value

Insider Trading

Get notified when an Novo Cure LTD insider buys or sells NVCR shares.

Notify only if

Operation

Value

Type

News

Receive news related to NovoCure Ltd

Track Activities on NVCR

Account